Clinical trial
Naproxen Versus Placebo as Adjunct Treatment of Cellulitis: A Randomized Controlled Trial
NCT07665476 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Naproxen Versus Placebo as Adjunct Treatment of Cellulitis: A Randomized Controlled Trial
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- December 1, 2031
- Enrollment
- 884 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cellulitis, infection, skin and soft tissue infections (sstis), skin disease, infectious